{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07042",
      "entity_text" : "Epo-Cy5.5",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_1594" ],
      "TissueType" : [ "uaz:CVCL_9S75" ],
      "Organ" : [ "uberon:UBERON:0000479" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Since the tumor vascularization was significantly higher in the Epo co-medicated groups, which could have facilitated passive probe accumulation, the reduced Epo-Cy5.5 levels cannot be explained by a pharmacological effect but rather by down-regulation of EpoR.",
  "reading_complete" : "2020-08-03T18:42:04Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T18:40:50Z",
  "trigger" : "levels",
  "evidence" : [ "Epo-Cy5.5 levels" ],
  "pmc_id" : "4440446",
  "score" : 0
}